Skip to main content
Clinical Trials/NL-OMON39706
NL-OMON39706
Completed
Not Applicable

Diffusion-weighted magnetic resonance imaging (DW-MRI) as an imaging biomarker: reproducibility of measurements in liver and lung. - DW-MRI

niversitair Medisch Centrum0 sites14 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Metastasis
Sponsor
niversitair Medisch Centrum
Enrollment
14
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational non invasive

Investigators

Sponsor
niversitair Medisch Centrum

Eligibility Criteria

Inclusion Criteria

  • Volunteer study
  • \* Age 30\-50 or 60\-80 years
  • \* Able to remain supine for 30 minutes in the scanner
  • \* Written informed consent
  • Patient study
  • \* Age 18 years or older
  • \* Colorectal liver metastases or lung metastases, or primary lung cancer (histological confirmation only in uncertain metastatic deposits)
  • \* Minimum of one lesion \> 2cm in diameter in liver or lung respectively
  • \* Able to remain supine for 30 minutes in the scanner
  • \* Written informed consent

Exclusion Criteria

  • \* Contraindications for MRI
  • \* Antitumor treatment targeted on the evaluable liver metastasis
  • \* Antitumor treatment targeted less than 1 week prior to scan in malignant lung lesions
  • \* Claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials